Conserved MHC class I peptide binding motif between humans and rhesus macaques

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 283-291

  Dzuris, John L ^a   Sidney, John ^a   Appella, Ettore ^b   Chesnut, Robert W ^a   Watkins, David I ^c   Sette, Alessandro ^a  

^a Epimmune   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; GENETIC CONSERVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 0033957425     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.283     Document Type: Article

References (57)

1. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
2. Pamer, E., and P. Creswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
3. Kubo, R. T., A. Sette, H. M. Grey, E. Appella, K. Sakaguchi, N-Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, et al. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913.
4. del Guercio, M.-F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1995. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685.
5. Sidney, J., M.-F. del Guercio, S. Southwood, V. H. Englehard, E. Appella, H.-G. Rammensee, K. Faulk, O. Rotzscke, M. Takiguchi, R. T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247.
6. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:178.
7. d exploits a 4 residue peptide binding motif. J. Exp. Med. 178:1877.
8. ds: sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1681.
9. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing self-peptides eluted from MHC molecules. Nature 351:290.
10. k restricted T-cell epitopes within the Influenza A/PR/8/34 virus hemagglutinin. J. Virol. 65:5401.
11. b-restricted cytotoxic T-cell epitope in the NS1 protein of influenza-virus using an MHC allele-specific motif. Virology 193:289.
12. kml restricted peptide motifs. J. Immunother. 14:144.
13. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1991. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:6342.
14. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
15. Rognan, D., S. Krebs, O. Kuonen, J. R. Lamas, J. A. Lopez de Castro, and G. Folkers. 1997. Fine specificity of antigen binding to two class I major histocompatability proteins (B*2705 and B*2703) differing in a single amino acid residue. J. Comput. Aided Mol. Des. 11:463.
16. Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics. In press.
17. Sette, A., and J. Sidney. 1998. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opinion. In Immunol. 10:478.
18. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17:261.
19. Bertoni, R., A. Sette, J. Sidney, L. G. Guidotti, M. Shapiro, R. Purcell, and F. V. Chisari. 1998. Human class I supertypes and CTL repertoires extend to chimpanzees. J. Immunol. 61:4447.
20. Allen, T. M., J. Sidney, M. F. del Guercio, R. L. Glickman, G. L. Lensmeyer, D. A. Wiebe, R. DeMars, C. D. Pauza, R. P. Johnson, A. Sette, and D. I. Watkins. 1998. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J. Immunol. 160:6062.
21. Boyson, J. E., C. Shufflebotham, L. F. Cadavid, J. A. Urvater, L. A. Knapp, A. L. Hughes, and D. I. Watkins. 1996. The MHC class I genes of the rhesus monkey: different evolutionary histories of the MHC class I and II genes in primates. J. Immunol. 156:4656.
22. Philipp, M. T., and B. J. Johnson. 1994. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. Trends Microbiol. 2:431.
23. Arankalle, V. A., M. S. Chada, L. P. Chobe, R. Nair, and K. Banerjee. 1995. Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus. J. Med. Virol. 46:358.
24. Tsarev, S. A., T. S. Tsarev, S. U. Emerson, S. Govindarajan, M. Shapiro, J. L. Gerin, and R. H. Purcell. 1997. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 15:1834.
25. Parashar, U. D., J. S. Bresee, J. R. Gentsch, and R. I. Glass. 1998. Rotavirus. Emerg. Infect. Dis. 4:561.
26. Fujioka, H., P. Millet, Y. Maeno, S. Nakazawa, Y. Ito, R. J. Howard, W. E. Collins, and M. Aikawa. 1994. A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp. Parasitol. 78:371.
27. Millet, P., K. K. Grady, M. Olsen, G. G. Galland, J. S. Sullivan, C. L. Morris, B. B. Richardson, W. E. Collins, and R. L. Hunter. 1995. Use of the rhesus monkey as an experimental model to test the degree of efficacy of an anti-sporozoite peptide malarial vaccine candidate combined with copolymer-based adjuvants. Am. J. Trop. Med. Hyg. 52:328.
28. Hulskotte, E. G., A. M. Geritti, and A. D. Osterhaus. 1998. Towards an HIV-1 vaccine: lessons from studies in macaque models. Vaccine 16:904.
29. Rausch, D. M., E. A. Murray, and L. E. Eiden. 1999. The SIV-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases. J. Leukocyte Biol. 65:466.
30. mac infection of macaque monkeys: a review J. Med. Primatol. 19:109.
31. Daniel, M. D., N. Letvin, N. King, M. Kannagi, P. Sehgal, and R. Hunt. 1985. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228: 1201.
32. Klatzmann, D., F. Barre-Sinoussi, M. T. Nugeyre, C. Danguet, C. Vilmer, C. Griscelli, F. Brun-Vezinet, C. Rouzioux, J. C. Gluckman, J. C. Cherman, and L. Montagnier. 1984. Selective tropism of lymphadenopathy associated virus (LAV) for helper-induced T-lymphocytes. Science 225:59.
33. Chen, Z., P. Zhou, D. D. Ho, N. R. Landau, and P. A. Marx. 1997. Genetically divergent strains of simian immunodeficiency virus uses CCR5 as a coreceptor for entry. J. Virol. 71:2705.
34. Hill, C. M., H. Deng, D. Unutmaz, V. N. Kewalramani, L. Bastiani, M. K. Gorny, S. Zolla-Pazner, and D. R. Littman. 1997. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71:6296.
35. Gotch, F., D. Dixon, A. Gallimore, S. McAdam, and A. McMichael. 1993. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2 and SIV. J. Med. Primatol. 22:119.
36. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A*0201 molecules. Cell 74:929.
37. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114.
38. Evans, D. T., D. H. O'Connor, P. Jing, J. L. Dzuris, J. Sidney, J. daSilva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, et al. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:1270.
39. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6Å resolution. J. Mol. Med. 219: 277.
40. Guo, H.C., T. S. Jardetzky, T. P. Garrett, W. S. Lane, J. L. Strominger, and D. C. Wiley. 1992. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364.
41. Parham, P., E. J. Adams, and K. L. Arnett. 1995. The origins of HLA-A,B,C polymorphism, Immunol. Rev. 143:141.
42. Miller, M. D., H. Yamamoto, A. L. Hughes, D. I. Watkins, and N. L. Letvin. 1991. Definition of an epilope and MHC class I molecule recognized by gagspeciftc cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol 147:320.
43. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
44. Rotzschke, O., K. Falk, S. Stevanovic, V. Gnau, G. Jung, and H-G. Rammensee. 1994 Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39:74.
45. Falk, K., O. Rotzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1995. Peptide motifs of HLA-B38 and -B39 molecules. Immunogenetics 41:162.
46. Fleischauer, K., D. Avila, F. Vilbois, C. Traversari, C. Bordignon, and H. J. Wallny. 1994. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens 44:311.
47. Harris, P. E., A. Colovai, Z. Liu, R. D. Favera, and N. Suciu-Foca. 1993. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. J. Immunol. 151:5966.
48. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
49. Falk, K., O. Rotzschke, M. Takiguchi, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1995. Peptide motifs of HLA-B58, B60, B61 and B62 molecules. Immunogenetics 41:165.
50. Kita, H., T. Moriyama, T. Kaneko, K. Hiroishi, I. Harase, H. Miura, I. Nakamura, H. Inamori, T. Kodama, S. Ohnishi, et al. 1995. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro. J. Med. Virol. 45:386.
51. Sette, A., A, Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol 153:5586.
52. Falk, K., O. Rotzschke, M. Takiguchi, B. Grabovac, V. Gnau, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11,-A31 and -A33 molecules. Immunogenetics 40:238.
53. DiBrino, M., K. C. Parker, J. Shiloach, R. V. Turner, T. Tsuchida, M. Garfield, W. E. Biddison, and J. E. Coligan. 1994. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J. Immunol. 152:620.
54. DiBrino, M., T. Tsuchida, R. V. Turner, K. C. Parker, J. E. Coligan, and W. E. Biddison. 1993. HLA-A1 and HLA-A3 T-cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151: 5930.
55. DiBrino, M., K. C. Parker, J. Shiloach, M. Knierman, J. Lukszo, R. V. Turner, W. B. Biddison, and J. E. Coligan. 1993. Endogenous peptides bound to HLA-A3 posses a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 90:1508.
56. DiBrino, M., K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1994. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J. Biol. Chem. 269:32426.
57. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439.